» Articles » PMID: 11819793

Carcinogenic Potential of Duodenal Reflux Juice from Patients with Long-standing Postgastrectomy

Overview
Specialty Gastroenterology
Date 2002 Jan 31
PMID 11819793
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Aim: To determine whether study on the carcinogenic potential of reflux juice from patients with remote gastrectomy could clarify the inherent relationship between duodenal reflux and gastric stump cancer.

Methods: A total of 37 reflux juice samples (13 Billroth I, 24 Billroth II) were employed in the present study. A two-stage transformation assay using BALB/c 3T3 cells was carried out to test the initiating or promoting activity of these samples.

Results: Two of 18 (11.1%) reflux samples exerted initiating activities, whereas 9/19 (47.4%) samples enhanced the MNNG-initiating cell transformation, suggesting the duodenal reflux juice might more frequently possess the tumor-promoter activity (P = 0.029). In addition, there was no difference in initiating activities of the samples irrespective of surgical procedures (P = 0.488), while Billroth II samples exhibited stronger tumor-promoter activity than Billroth I samples (P = 0.027). Furthermore, the promoter activities were well correlated with the histological changes of the stomas (r(s) = 0.625, P = 0.004), but neither their cytotoxicities nor initiating activities had this correlation (Probabilities were 0.523 and 0.085, respectively).

Conclusion: The duodenal reflux juice from patients with remote postgastrectomy did have carcinogenic potential, and suggested that tumor-promoting activity should principally account for the high incidence of gastric cancer in gastrectomy patients. In contrast, it is difficult to explain the high stump-cancer incidence with the N-nitroso compounds theory-a popular theory for the intact stomach carcinogenesis, and it seemed to be justified to focus chemo-prevention of this cancer on the tumor-promoting potential of reflux juice.

Citing Articles

Evaluation of estrogen receptor expression and its relationship with clinicopathologic findings in gastric cancer.

Saeidi H, Nasiri M, Shahidsales S, Kermani A, Hematti S, Roodbari S Adv Biomed Res. 2015; 4:177.

PMID: 26605216 PMC: 4617152. DOI: 10.4103/2277-9175.164013.


Association of laryngeal cancer with previous gastric resection.

Cammarota G, Galli J, Cianci R, De Corso E, Pasceri V, Palli D Ann Surg. 2004; 240(5):817-24.

PMID: 15492563 PMC: 1356487. DOI: 10.1097/01.sla.0000143244.76135.ca.


Expression of estrogen receptor and estrogen receptor messenger RNA in gastric carcinoma tissues.

Zhao X, Gu S, Liu S, Pan B World J Gastroenterol. 2003; 9(4):665-9.

PMID: 12679906 PMC: 4611424. DOI: 10.3748/wjg.v9.i4.665.

References
1.
Sugiyama Y, Sohma H, Ozawa M, Hada R, Mikami Y, Konn M . Regurgitant bile acids and mucosal injury of the gastric remnant after partial gastrectomy. Am J Surg. 1987; 153(4):399-403. DOI: 10.1016/0002-9610(87)90586-1. View

2.
Fukuzawa K, Noguchi Y, Matsumoto A . Alterations in DNA proliferation in gastric stump mucosa with special reference to topography. Surgery. 1996; 119(2):191-7. DOI: 10.1016/s0039-6060(96)80168-1. View

3.
Reed P, Smith P, Haines K, House F, Walters C . Gastric juice N-nitrosamines in health and gastroduodenal disease. Lancet. 1981; 2(8246):550-2. DOI: 10.1016/s0140-6736(81)90939-9. View

4.
Caygill C, Hill M, KIRKHAM J, Northfield T . Mortality from gastric cancer following gastric surgery for peptic ulcer. Lancet. 1986; 1(8487):929-31. DOI: 10.1016/s0140-6736(86)91041-x. View

5.
Offerhaus G, Tersmette A, Huibregtse K, Van de Stadt J, Tersmette K, Stijnen T . Mortality caused by stomach cancer after remote partial gastrectomy for benign conditions: 40 years of follow up of an Amsterdam cohort of 2633 postgastrectomy patients. Gut. 1988; 29(11):1588-90. PMC: 1433828. DOI: 10.1136/gut.29.11.1588. View